India to Poland: Escitalopram Export Trade Route

The India to Poland Escitalopram corridor is one of India's established pharmaceutical export routes, with 202 shipments documented worth a combined $6.9M USD. The route is dominated by SANDOZ PRIVATE LIMITED, which alone accounts for roughly 70% of all export value, reflecting the consolidated nature of India's escitalopram manufacturing sector.

Across 12 active suppliers, the average shipment value stands at $34.2K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 84% of all shipments, consistent with escitalopram's non-urgent bulk-order profile.

Shipment activity peaks during April–June, with an average transit time of 23 days port-to-port. The route has recorded an annual growth rate of 12.5%, placing it at rank #20 among India's top escitalopram export destinations globally.

On the import side, key buyers of Indian escitalopram in Poland include LEK S.A., LEK S A, LEK S.A. and 18 others. LEK S.A. is the single largest importer with 93 shipments valued at $2.8M USD.

India's escitalopram exports to Poland are driven primarily by a handful of large-scale manufacturers. SANDOZ PRIVATE LIMITED with 124 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 12 active exporters signals a competitive but concentrated market — buyers in Poland benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — SANDOZ PRIVATE LIMITED, SANDOZ PRIVATE LIMITED , MACLEODS PHARMACEUTICALS LTD — together account for 93% of total trade value on this route. The average shipment value of $34.2K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as material no. - 42034110 escitalopram oxa and material no. 42034100 escitalopramoxa fct 20mg in91 sh eu 05, suggesting that buyers in Poland tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, LEK S.A. is the largest importer with 93 shipments worth $2.8M USD — representing 40% of all escitalopram imports from India on this route. A total of 21 buyers are active on this corridor.